WallStSmart
NXL

Nexalin Technology Inc.

NASDAQ: NXL · HEALTHCARE · MEDICAL DEVICES

$0.36
+2.42% today

Updated 2026-04-30

Market cap
$8.34M
P/E ratio
P/S ratio
27.63x
EPS (TTM)
$-0.50
Dividend yield
52W range
$0 – $2
Volume
0.6M

Nexalin Technology Inc. (NXL) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-0.9%
Last 4 quarters
Revenue YoY growth
+532.5%
Most recent quarter
EPS YoY growth
+48.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-4.1%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-7.4%
2026-02-25
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-25$-0.13-8.3%$0.56$0.52-7.4%
2025-12-03$-0.13-8.3%$0.97$0.96-0.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.12$-0.13-8.3%$171895.00+532.5%
2025-09-30$-0.12$-0.13-8.3%$18149.00-49.6%
2025-06-30$-0.14$-0.10+28.6%$70588.00+163.0%
2025-03-31$-0.13$-0.15-15.4%$41015.00-47.9%
2024-12-31$-0.12$-0.25-108.3%$27179.00+32.3%
2024-09-30$-0.12$-0.23-91.7%$36031.00+49.4%
2024-06-30$-0.17$26840.00-24.5%
2024-03-31$-0.14$78671.00+157.4%
2023-12-31$-0.11$20536.00
2023-09-30$-0.31$24113.00
2023-06-30$-0.11$35540.00
2023-03-31$-0.10$30560.00

Frequently asked questions

Has Nexalin Technology Inc. beaten earnings estimates?
Nexalin Technology Inc. has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -0.9% over the last 4 quarters.
How does NXL stock react to earnings?
NXL stock has moved an average of -4.1% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Nexalin Technology Inc.'s revenue growth rate?
Nexalin Technology Inc. reported year-over-year revenue growth of +532.5% in its most recent quarter, with EPS growing +48.0% year-over-year.